SCHEMBL713328

SCHEMBL713328

[c]1ccccc1-c1onc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 1/20 0.36
IP6K1 Q92551 9/20 0.33
IP6K3 Q96PC2 7/20 0.33
IP6K2 Q9UHH9 7/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TP53 P04637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
NPC1 O15118 2/20 0.33
POLB P06746 1/20 0.33
GPR3 P46089 1/20 0.31
TSHR P16473 2/20 0.31
LMNA P02545 2/20 0.31
USP2 O75604 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31001160 0.78 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2HPGDIP6K1IP6K3
SCHEMBL1837436 0.73 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2HPGDIP6K1IP6K3
SCHEMBL6691319 0.72 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2HPGDIP6K1IP6K3
SCHEMBL2492556 0.71 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2HPGDIP6K1IP6K3
SCHEMBL28586612 0.68 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HPGDKDM4EKMT2A
SCHEMBL3137519 0.68 ESR1 (0.47) SMN1; SMN2LMNA
SCHEMBL23458464 0.67 IP6K1 (0.51) ALDH1A1SMN1; SMN2HPGDIP6K1IP6K3
SCHEMBL28601248 0.67 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2HPGDIP6K1IP6K3
SCHEMBL28772091 0.67 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2HPGDIP6K1IP6K3
SCHEMBL28526902 0.67 CYP2A6 (0.42) ALDH1A1SMN1; SMN2HPGDIP6K1IP6K3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771843-B2 Fluorene derivative, organic compound, and light-emitting element, light-emitting device, and electronic device using the compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-07-08 US disclosed
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound AFF2, MAPRE2, AFF4 ALDH1A1 1391/4885SMN1; SMN2 4102/4885HPGD 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.